Medpace Holdings EPS - Earnings per Share 2014-2025 | MEDP
Medpace Holdings annual and quarterly earnings per share history from 2014 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Medpace Holdings EPS for the quarter ending March 31, 2025 was $3.67, a 14.69% increase year-over-year.
- Medpace Holdings EPS for the twelve months ending March 31, 2025 was $13.10, a 33.54% increase year-over-year.
- Medpace Holdings 2024 annual EPS was $12.63, a 42.23% increase from 2023.
- Medpace Holdings 2023 annual EPS was $8.88, a 21.98% increase from 2022.
- Medpace Holdings 2022 annual EPS was $7.28, a 51.35% increase from 2021.
| Medpace Holdings Annual EPS |
| 2024 |
$12.63 |
| 2023 |
$8.88 |
| 2022 |
$7.28 |
| 2021 |
$4.81 |
| 2020 |
$3.84 |
| 2019 |
$2.67 |
| 2018 |
$1.97 |
| 2017 |
$0.98 |
| 2016 |
$0.37 |
| 2015 |
$-0.28 |
| 2014 |
$-0.50 |
| 2013 |
$0.95 |
| Medpace Holdings Quarterly EPS |
| 2025-03-31 |
$3.67 |
| 2024-12-31 |
$3.67 |
| 2024-09-30 |
$3.01 |
| 2024-06-30 |
$2.75 |
| 2024-03-31 |
$3.20 |
| 2023-12-31 |
$2.46 |
| 2023-09-30 |
$2.22 |
| 2023-06-30 |
$1.93 |
| 2023-03-31 |
$2.27 |
| 2022-12-31 |
$2.08 |
| 2022-09-30 |
$2.05 |
| 2022-06-30 |
$1.46 |
| 2022-03-31 |
$1.69 |
| 2021-12-31 |
$1.32 |
| 2021-09-30 |
$1.29 |
| 2021-06-30 |
$1.06 |
| 2021-03-31 |
$1.14 |
| 2020-12-31 |
$1.35 |
| 2020-09-30 |
$1.09 |
| 2020-06-30 |
$0.64 |
| 2020-03-31 |
$0.76 |
| 2019-12-31 |
$0.80 |
| 2019-09-30 |
$0.63 |
| 2019-06-30 |
$0.73 |
| 2019-03-31 |
$0.51 |
| 2018-12-31 |
$0.60 |
| 2018-09-30 |
$0.52 |
| 2018-06-30 |
$0.45 |
| 2018-03-31 |
$0.40 |
| 2017-12-31 |
$0.30 |
| 2017-09-30 |
$0.25 |
| 2017-06-30 |
$0.23 |
| 2017-03-31 |
$0.20 |
| 2016-12-31 |
$-0.02 |
| 2016-09-30 |
$0.13 |
| 2016-06-30 |
$0.15 |
| 2016-03-31 |
$0.11 |
| 2015-12-31 |
$0.00 |
| 2015-09-30 |
$0.00 |
| 2014-12-31 |
$0.00 |
| 2013-12-31 |
$0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Services |
$8.687B |
$2.109B |
|
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
|
